• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Cadence Welcomes Bob White to Board of Directors

    9/12/24 10:57:00 AM ET
    $SNN
    Industrial Specialties
    Health Care
    Get the next $SNN alert in real time by email

    STAUNTON, Va., Sept. 12, 2024 /PRNewswire/ -- Cadence, Inc., a leading provider of vertically integrated contract manufacturing solutions to the MedTech and Pharma markets, is pleased to announce the appointment of Bob White to its Board of Directors.  Mr. White brings over 25 years of business leadership experience and a proven track record in operational excellence, technological innovation, and strategic growth to Cadence.

    Cadence Welcomes Bob White to its Board of Directors, September 2024.

    Mr. White has demonstrated exceptional skills in managing global locations, having held senior positions at Medtronic, GE Healthcare, and IBM.  He recently served as Executive Vice President and Group President for Medtronic, where he led five global businesses with 25,000 employees across 70 countries and 13 manufacturing facilities, achieving consistent above-market growth.  During his tenure, he also successfully completed seven acquisitions, a joint venture, and a multi-billion-dollar divestiture. 

    "Bob will be an excellent addition to our Board," stated Matt Jennings, Cadence's Chairman of the Board.  "His impressive track record in global business leadership and his commitment to innovation and growth will be instrumental as Cadence continues to advance its strategic goals and drive success, and he will be valuable to both the Board and Cadence's leadership team with their go-to market approach."

    In addition, Mr. White currently serves as an Independent Director for Smith & Nephew (NYSE:SNN) and formerly held board positions at Mozarc Medical and CARE Hospitals, a multi-specialty healthcare provider with 14 hospitals in six cities across five states of India.

    He holds an MBA from Case Western Reserve University and a Bachelor of Business Administration from Cleveland State University.  His extensive medical device manufacturing experience and strategic vision make him a valuable addition to Cadence's Board of Directors.

    About Cadence, Inc. – Cadence is a vertically integrated, medical device contract manufacturing organization serving the medical device, diagnostics, and drug delivery markets, providing best-in-class product design and development support through complete manufacturing of finished devices.  Cadence employs approximately 800 people worldwide with its corporate headquarters in Staunton, Virginia and additional locations in Connecticut, Pennsylvania, Rhode Island, Wisconsin, Florida, and Costa Rica.  For more information on Cadence, please visit our website at cadenceinc.com. 

    Cadence, Inc. Logo, September 2024.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cadence-welcomes-bob-white-to-board-of-directors-302246732.html

    SOURCE Cadence, Inc.

    Get the next $SNN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNN

    DatePrice TargetRatingAnalyst
    4/25/2025Buy → Hold
    HSBC Securities
    3/12/2025Buy → Neutral
    UBS
    11/6/2024Buy → Hold
    Berenberg
    11/1/2024Buy → Hold
    Deutsche Bank
    7/24/2024Buy
    Deutsche Bank
    6/5/2024Neutral → Buy
    UBS
    11/28/2023Underweight → Equal Weight
    Barclays
    11/3/2023Neutral → Overweight
    JP Morgan
    More analyst ratings

    $SNN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Smith & Nephew downgraded by HSBC Securities

    HSBC Securities downgraded Smith & Nephew from Buy to Hold

    4/25/25 8:30:48 AM ET
    $SNN
    Industrial Specialties
    Health Care

    Smith & Nephew downgraded by UBS

    UBS downgraded Smith & Nephew from Buy to Neutral

    3/12/25 7:34:02 AM ET
    $SNN
    Industrial Specialties
    Health Care

    Smith & Nephew downgraded by Berenberg

    Berenberg downgraded Smith & Nephew from Buy to Hold

    11/6/24 6:23:06 AM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    SEC Filings

    View All

    SEC Form 6-K filed by Smith & Nephew SNATS Inc.

    6-K - SMITH & NEPHEW PLC (0000845982) (Filer)

    9/9/25 1:35:09 PM ET
    $SNN
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by Smith & Nephew SNATS Inc.

    6-K - SMITH & NEPHEW PLC (0000845982) (Filer)

    9/9/25 1:19:26 PM ET
    $SNN
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by Smith & Nephew SNATS Inc.

    6-K - SMITH & NEPHEW PLC (0000845982) (Filer)

    9/2/25 8:11:20 AM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $SNN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

    Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant and support its further adoption. Substantial investment into research to expand access and indications have led to these important results designed to help surgeons treat more patients who suffer from rotator cuff tears and other tendon and extra-articular ligament injuries throughout the body: AAOS Clinical Practice Guideline (CPG) on the Management of Rotator Cuff Injuries1For the first time, recent updates to the American Academy of Orthopaedic Surgeons (AAOS) CPG on the Management of Rotato

    9/11/25 8:00:00 AM ET
    $SNN
    Industrial Specialties
    Health Care

    Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System

    Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient's own platelets and plasma that, once applied, may assist the natural healing process by maintaining a moist wound environment.  CENTRIO PRP System can help manage chronic exuding wounds including but not limited to diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers, and tunnelling wounds. Thanks to a National Coverage Determination (NCD) made effective April 2021, autologous PRP for the treatment of chronic non-healing wounds for diabetic patients has CMS coverage, when prepa

    9/3/25 10:15:58 AM ET
    $SNN
    Industrial Specialties
    Health Care

    Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

    Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot & Ankle.  Building on the long-standing success and performance of the best-in-class anchor fixation strength of the Q-FIX Family versus competitive devices*, the new Q-FIX KNOTLESS All-Suture Anchor raises the bar for all-suture anchor technology. With proprietary features and capabilities, the Q-FIX KNOTLESS All-Suture Anchor aims to set a new benchmark for fixation strength and offer surgeons a reason to reassess their joint repair approach, inclu

    7/7/25 10:00:00 AM ET
    $SNN
    Industrial Specialties
    Health Care

    SEC Form 3: Plc Nephew & Smith claimed ownership of 5,428,680 units of Class A Common Stock and claimed ownership of 16,534,814 units of Class B Common Stock

    3 - SMITH & NEPHEW PLC (0000845982) (Reporting)

    2/12/21 6:00:30 AM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Leadership Updates

    Live Leadership Updates

    View All

    Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

    Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee.  As both a senior management consultant and investment banker, Ajay has advised CEOs and Boards at some of the world's leading healthcare companies, helping deliver substantial shareholder value.  Ajay's experience includes 25 years with McKinsey & Company where he was a Senior Partner and held multiple leadership roles including Global Head of Strategy across all industries, Global Head of Strategy

    6/23/25 8:00:00 AM ET
    $LAZ
    $SNN
    Investment Managers
    Finance
    Industrial Specialties
    Health Care

    Cadence Welcomes Bob White to Board of Directors

    STAUNTON, Va., Sept. 12, 2024 /PRNewswire/ -- Cadence, Inc., a leading provider of vertically integrated contract manufacturing solutions to the MedTech and Pharma markets, is pleased to announce the appointment of Bob White to its Board of Directors.  Mr. White brings over 25 years of business leadership experience and a proven track record in operational excellence, technological innovation, and strategic growth to Cadence. Mr. White has demonstrated exceptional skills in managing global locations, having held senior positions at Medtronic, GE Healthcare, and IBM.  He recent

    9/12/24 10:57:00 AM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Smith & Nephew SNATS Inc.

    SC 13D - SMITH & NEPHEW PLC (0000845982) (Subject)

    7/9/24 12:00:10 PM ET
    $SNN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - SMITH & NEPHEW PLC (0000845982) (Subject)

    2/3/21 1:13:21 PM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Financials

    Live finance-specific insights

    View All

    Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research

    New York, United States, March 03, 2025 (GLOBE NEWSWIRE) -- The global demand for wound care products is increasing as the number of patients with chronic and acute wounds rises. Market leaders continually focus on introducing innovative wound care products to meet unmet demand. As a result, more people are using conventional, bioactive, and other wound care products. In addition, governments in developing nations and other for-profit and non-profit organizations are increasingly focusing on various awareness campaigns to educate the public about innovative product offerings and therapeutic options for chronic and advanced wounds. Download Free Sample Report PDF @ https://straitsresearc

    3/3/25 8:20:00 AM ET
    $SNN
    Industrial Specialties
    Health Care

    Wound Care Market Will Reach USD 31.81 Billion by 2030 on the Back of Growth in the North American Market

    New York, United States, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The global demand for Wound Care products is increasing as the number of patients with chronic and acute wounds rises. Market leaders continually focus on introducing innovative wound care products to meet unmet demand. As a result, more people are using conventional, bioactive, and other wound care products. In addition, governments in developing nations and other for-profit and non-profit organizations are increasingly focusing on various awareness campaigns to educate the public about innovative product offerings and therapeutic options for chronic and advanced wounds. Get a Free Sample Copy of This Report https://stra

    8/29/22 3:20:00 PM ET
    $SNN
    Industrial Specialties
    Health Care

    Healiva® Acquires Two Wound-healing Cell Therapy Assets From Smith+Nephew

    Adds two close-to-market innovative technologies to Healiva's® growing portfolio of end-to-end care for chronic wounds Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of two innovative cell therapy assets from Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology business. The acquisition enables Healiva® to establish one of the world's broadest portfolios of affordable, personalized, end-to-end wound care consisting of enzyme technology, autologous & allogenic cell therapies, and medical devices. Financial details have not been disclosed. The first asset, EpiDex®, is an

    6/1/22 2:30:00 AM ET
    $SNN
    Industrial Specialties
    Health Care